Over the past decade, Immusmol specialized in the development of antibodies against low molecular weight compounds (<900 Daltons), eventually building a portfolio of unique primary antibodies and ELISA kits for research use.
50 + unique primary antibodies
We develop monoclonal & polyclonal antibodies and staining procedures for the visualization of small molecules in cells & tissues.
80+ ELISAs cross-validated by LC-MS
Our team develops highly sensitive ELISA kits to measure amino acids and their metabolites in biological samples.
600+ clients served worldwide
We deliver our products worldwide through Fedex and developed a network of trusted distributors in America, Europe, Africa, Asia, and Oceania.
Company Details
- Employees
- 12
- Founded
- -
- Address
- 229 Cours De L'argonne, Bordeaux,aquitaine 33000,france
- Phone
- +33 0 5 6431 1170
- co****@****mol.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- immusmol.com
- Keywords
- Small molecule antibodies, Small molecule detection, Small molecule visualization, Small molecule quantification, Custom small molecule antibodies, Therapeutic monoclonal antibodies, Tryptophan metabolism, Kynurenine pathway, Anti-hapten antibodies.
- HQ
- Bordeaux, Aquitaine
Immusmol Questions
Immusmol's helpline number is +33 0 5 6431 1170
Immusmol's website is immusmol.com
Immusmol's LinkedIn profile is https://fr.linkedin.com/company/immusmol
Immusmol has
12 employees.
View email and phone details for 12
employees at Immusmol.
Immusmol's industry is
Biotechnology Research
Immusmol's top competitors are
Fluofarma,
Majus Therapeutics,
Immunext,
Aelis Farma,
Osivax,
Gynov,
Synvec,
Explicyte,
Ysopia Bioscience,
Treefrog Therapeutics.
Immusmol's support email address is contact@immusmol.com
Immusmol's categories are Biotechnology Research
Immusmol's founding year is 2012
